# Oxybutynin Chloride Extended Release

NDC: 42291-635
Generic name: Oxybutynin Chloride
Labeler / Manufacturer: AvKARE
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20160309

FDA application: ANDA078503

## Active ingredients

- OXYBUTYNIN CHLORIDE: 15 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42291-635"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42291-635
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=94471401-a516-0fe7-ec9c-447dd2bee972